EEG signatures of psychotropic medications: opportunities and challenges for translational psychiatry

Over the past few decades, neuroimaging has been increasingly investigated as a tool for identifying individualised markers to support the diagnosis and treatment of mental health disorders. Studies of brain function using electroencephalography (EEG) have provided important insights into the pathophysiology and effects of treatment in various psychiatric disorders. However, emerging evidence suggests that disorder-specific neural features may not be contained within discrete diagnostic boundaries; rather, psychiatric disorders may be better characterised by transdiagnostic neurobiological phenotypes.